Brain Tumor Diagnostics Market
Brain Tumor Diagnostics Market Research Report By Modality (Neuroimaging, Biopsy, Laboratory Tests, Genetic Testing), By Biomarker (IDH1, ATRX, BRAF, EGFR, MGMT), By Diagnostic Purpose (Pre-Operative Diagnosis, Post-Operative Monitoring, Treatment Selection, Prognosis Prediction), By Imaging Technique (Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Positron Emission Tomography (PET), Single Photon Emission Computed Tomography (SPECT)), By Sample Type (Tissue Biopsy, Blood, Cerebrospinal Fluid (CSF)) and By Region (North America, Europe, South America, Asia Pacific, Middle East and Africa- Forecast to 2032.
Brain Tumor Diagnostics Market Overview
As per MRFR analysis, the brain tumor diagnostics market size was estimated at 7.38 (USD Billion) in 2022. The brain tumor diagnostics market industry is expected to grow from 7.76(USD Billion) in 2023 to 12..